Manufacture of bone graft substitutes

• US 6,630,153 B2
• Filed: 02/23/2001
• Issued: 10/07/2003
• Est. Priority Date: 02/23/2001
• Status: Expired due to Fees

• Current Assignee: Smith & Nephew Incorporated (Smith & Nephew PLC)
• Original Assignee: Smith & Nephew Incorporated (Smith & Nephew PLC)
• Inventors: Long, Marc, Cooper, Michael B., Schryver, Jeff, Kinnane, Keith M., Allen, Trevor
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): Fubara, Blessing
• Application Number:
  US09/792,681
• Publication Number:
  US 20020160032A1
• Time in Patent Office: 956 Days
• Field of Search: 424/422, 424/426, 424/484, 424/423, 424/501
• US Class Current: 424/422
• CPC Class Codes: A61F 2/28 Bones joints A61F2/30
• CPC Class Codes: A61F 2/3094 Designing or manufacturing processes
• CPC Class Codes: A61F 2/4644 Preparation of bone graft, bone plugs or bone dowels, e.g. grinding or milling bone material bone material A61F2/28; disintegrating or milling devices B02C
• CPC Class Codes: A61F 2002/2817 Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
• CPC Class Codes: A61F 2002/2835 Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
• CPC Class Codes: A61F 2002/30062 (bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
• CPC Class Codes: A61F 2002/30303 polypod-shaped
• CPC Class Codes: A61F 2002/30677 Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
• CPC Class Codes: A61F 2210/0004 bioabsorbable
• CPC Class Codes: A61F 2230/0063 Three-dimensional shapes
• CPC Class Codes: A61F 2310/00203 containing alumina or aluminium oxide
• CPC Class Codes: A61F 2310/00293 containing a phosphorus-containing compound, e.g. apatite
• CPC Class Codes: A61F 2310/00329 Glasses, e.g. bioglass
• CPC Class Codes: A61L 2430/02 for reconstruction of bones; weight-bearing implants
• CPC Class Codes: A61L 27/00 Materials for grafts or prostheses or for coating grafts or prostheses dental prostheses A61C13/00; shape or structure of prostheses A61F2/00; use of preparations for artificial teeth A61K6/80; artificial kidneys A61M1/14
• CPC Class Codes: A61L 27/3608 Bone, e.g. demineralised bone matrix [DBM], bone powder
• CPC Class Codes: A61L 27/365 Bones
• CPC Class Codes: B30B 11/02 using a ram exerting pressure on the material in a moulding space

Abstract

The present invention is directed to methods and compositions for manufacturing a bone graft substitute. A powder compaction process is utilized to generate a shaped product comprised of a granulated bone material, such as demineralized bone matrix. In addition, a processing aid is utilized to facilitate compaction of the granulated bone material and for release of the product from the die.

Claims

1. A method of manufacturing a three-dimensional intricately shaped bone graft substitute comprising the step of dry powder compacting a bone material into said three-dimensional intricate shape.

2. The method of claim 1, wherein said bone material is an allograft material, a ceramic material, a polymer or combinations thereof.

3. The method of claim 1, wherein said material further comprises a processing aid composition.

4. The method of claim 3, wherein said processing aid composition is selected from the group consisting of stearic acid, calcium stearate, magnesium stearate, natural polymer, synthetic polymer, sugar, glycerol, and combinations thereof.

5. The method of claim 4, wherein said natural polymer is starch, gelatin, or combinations thereof.

6. The method of claim 4, wherein said synthetic polymer is methylcellulose, sodium carboxymethylcellulose, or hydropropylmethylcellulose.

7. The method of claim 2, wherein said allograft bone material is cortical-cancellous bone.

8. The method of claim 2, wherein said allograft bone material is demineralized bone matrix.

9. The method of claim 2, wherein said ceramic material is selected from the group consisting of hydroxylapatite, calcium sulphate, alumina, silica, calcium carbonate, calcium phosphate, calcium tartarate, bioactive glass, and combinations thereof.

10. The method of claim 1, wherein said substitute further comprises a biological agent.

11. The method of claim 10, wherein said biological agent is added to said material prior to said compaction step.

12. The method of claim 10, wherein said biological agent is added to said bone graft substitute subsequent to said compaction step.

13. The method of claim 10, wherein said agent is selected from the group consisting of a growth factor, an antibiotic, a strontium salt, a fluoride salt, a magnesium salt, a sodium salt, a bone morphogenetic factor, a chemotherapeutic agent, a pain killer, a bisphosphonate, a bone growth agent, an angiogenic factor, and combinations thereof.

14. The method of claim 13, wherein said growth factor is selected from the group consisting of platelet derived growth factor (PDGF), transforming growth factor b (TGF-b), insulin-related growth factor-I (IGF-I), insulin-related growth factor-II (IGF-II), fibroblast growth factor (FGF), beta-2-microglobulin (BDGF II), bone morphogenetic protein (BMP), and combinations thereof.

15. The method of claim 13, wherein said antibiotic is selected from the group consisting of tetracycline hydrochloride, vancomycin, cephalosporins, and aminoglycocides such as tobramycin, gentamicin, and combinations thereof.

16. The method of claim 13, wherein said factor is selected from the group consisting of proteins of demineralized bone, demineralized bone matrix (DBM), bone protein (BP), bone morphogenetic protein (BMP), osteonectin, osteocalcin, osteogenin, and combinations thereof.

17. The method of claim 13, wherein said agent is selected from the group consisting of cis-platinum, ifosfamide, methotrexate, doxorubicin hydrochloride, and combinations thereof.

18. The method of claim 13, wherein said pain killer is selected from the group consisting of lidocaine hydrochloride, bipivacaine hydrochloride, non-steroidal anti-inflammatory drugs such as ketorolac tromethamine, and combinations thereof.

19. The method of claim 1, wherein particles of said material are less than about 10 millimeters in diameter.

20. The method of claim 1, wherein particles of said material are less than about 250 μ

m in diameter.

21. The method of claim 1, wherein particles of said material are in a range of about 50 to 180 microns.

32. The method of claim 1, wherein said shape generally has the shape of a toy jack.

33. The method of claim 1, wherein said shape is a three-dimensional six-armed star shape.

22. A method of manufacturing a three-dimensional intricately shaped bone graft substitute comprising the steps of:

obtaining a bone material;

granulating said material; and

subjecting said bone material to a dry powder compaction process; and

wherein a three-dimensional intricate shape is formed by said dry powder compaction process.

23. The method of claim 22, wherein said dry powder compaction process utilizes a withdrawal press, wherein said press comprises:

a stationary lower punch;

a moveable die;

a moveable upper punch; and

a moveable lower punch, wherein said stationary lower punch is contained within said moveable lower punch and wherein said moveable lower punch is contained within the moveable die.

24. A method of manufacturing an intricately shaped bone graft substitute from bone material, said method comprising the steps of:

providing a stationary lower punch and a moveable lower punch which is vertically moveable about the stationary lower punch, a moveable die having at least one cavity that is vertically moveable about the moveable lower punch and positionable generally above the stationary lower punch, and a moveable upper punch that is vertically moveable inside the moveable die;

positioning the moveable die generally above the stationary lower punch;

positioning the moveable upper punch generally above the moveable die;

introducing the granulated bone material into the cavity of the moveable die;

moving the moveable upper punch to contact the bone material in opposition to the moveable lower punch and stationary lower punch; and

moving the moveable upper punch further into the cavity of the moveable die, moving the moveable die, and moving the moveable lower punch all at the same time but with different relative amplitudes,

whereby said moving steps form the material into the intricately shaped bone graft substitute.

25. The method of claim 24, wherein the steps of the relative motions of the upper and lower punches effect a substantially uniform distribution of pressure within said material.

26. The method of claim 24, wherein at least one of the moving steps applies a force to the material in a range of about 0.2 to about 5 tons.

27. The method of claim 24, wherein at least one of the moving steps applies a force to the material in a range of about 0.2 to about 2 tons.

28. The method of claim 24, wherein at least one of the moving steps applies a force to the material in a range of about 0.5 to about 1 ton.

29. The method of claim 24, wherein said moving step of the moveable lower punch to the material is subsequent to the moving step of the moveable upper punch to the material.

30. The method of claim 24, wherein the lower punch is comprised of at least one of a stationary lower punch and a moveable lower punch vertically moveable about the stationary lower punch and moveable inside the cavity of the moveable die.

31. The method of claim 24, wherein the upper punch is comprised of at least one of a stationary upper punch and a moveable upper punch vertically moveable about the stationary upper punch and moveable inside the cavity of the moveable die.